238 related articles for article (PubMed ID: 29872959)
1. Role of Telomeric TRF2 in Orosphere Formation and CSC Phenotype Maintenance Through Efficient DNA Repair Pathway and its Correlation with Recurrence in OSCC.
Saha A; Roy S; Kar M; Roy S; Thakur S; Padhi S; Akhter Y; Banerjee B
Stem Cell Rev Rep; 2018 Dec; 14(6):871-887. PubMed ID: 29872959
[TBL] [Abstract][Full Text] [Related]
2. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
3. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
[TBL] [Abstract][Full Text] [Related]
4. Lactate Promotes Cancer Stem-like Property of Oral Sequamous Cell Carcinoma.
Zhao H; Hu CY; Chen WM; Huang P
Curr Med Sci; 2019 Jun; 39(3):403-409. PubMed ID: 31209810
[TBL] [Abstract][Full Text] [Related]
5. DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma.
Martin CE; Nguyen A; Kang MK; Kim RH; Park NH; Shin KH
Exp Cell Res; 2021 Aug; 405(1):112656. PubMed ID: 34033760
[TBL] [Abstract][Full Text] [Related]
6. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
7. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
[TBL] [Abstract][Full Text] [Related]
8. Radiation-induced DNA damage response and resistance in colorectal cancer stem-like cells.
Anuja K; Chowdhury AR; Saha A; Roy S; Rath AK; Kar M; Banerjee B
Int J Radiat Biol; 2019 Jun; 95(6):667-679. PubMed ID: 30753097
[No Abstract] [Full Text] [Related]
9. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.
Wang LH; Xu M; Fu LQ; Chen XY; Yang F
Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678
[TBL] [Abstract][Full Text] [Related]
10. Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma.
Roy S; Roy S; Kar M; Padhi S; Saha A; Anuja K; Banerjee B
J Oral Pathol Med; 2018 May; 47(5):492-501. PubMed ID: 29575240
[TBL] [Abstract][Full Text] [Related]
11. Tumor Budding, EMT and Cancer Stem Cells in T1-2/N0 Oral Squamous Cell Carcinomas.
Attramadal CG; Kumar S; Boysen ME; Dhakal HP; Nesland JM; Bryne M
Anticancer Res; 2015 Nov; 35(11):6111-20. PubMed ID: 26504037
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
[TBL] [Abstract][Full Text] [Related]
13. Ephrin A4-ephrin receptor A10 signaling promotes cell migration and spheroid formation by upregulating NANOG expression in oral squamous cell carcinoma cells.
Chen YL; Yen YC; Jang CW; Wang SH; Huang HT; Chen CH; Hsiao JR; Chang JY; Chen YW
Sci Rep; 2021 Jan; 11(1):644. PubMed ID: 33436772
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features.
Ghosh RD; Ghuwalewala S; Das P; Mandloi S; Alam SK; Chakraborty J; Sarkar S; Chakrabarti S; Panda CK; Roychoudhury S
Sci Rep; 2016 Apr; 6():23932. PubMed ID: 27045798
[TBL] [Abstract][Full Text] [Related]
15. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.
Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J
Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100
[TBL] [Abstract][Full Text] [Related]
16. Telomeric repeat-binding factor 2: a marker for survival and anti-EGFR efficacy in oral carcinoma.
Benhamou Y; Picco V; Raybaud H; Sudaka A; Chamorey E; Brolih S; Monteverde M; Merlano M; Lo Nigro C; Ambrosetti D; Pagès G
Oncotarget; 2016 Jul; 7(28):44236-44251. PubMed ID: 27329590
[TBL] [Abstract][Full Text] [Related]
17. Sphere-forming-like cells (squamospheres) with cancer stem-like cell traits from VX2 rabbit buccal squamous cell carcinoma.
Chen YK; Huang AH; Lin LM
Int J Oral Sci; 2014 Dec; 6(4):212-8. PubMed ID: 25012868
[TBL] [Abstract][Full Text] [Related]
18. Expression of TRF2 and its prognostic relevance in advanced stage cervical cancer patients.
Ozden S; Tiber PM; Ozgen Z; Ozyurt H; Serakinci N; Orun O
Biol Res; 2014 Nov; 47(1):61. PubMed ID: 25654471
[TBL] [Abstract][Full Text] [Related]
19. XPF with mutations in its conserved nuclease domain is defective in DNA repair but functions in TRF2-mediated telomere shortening.
Wu Y; Zacal NJ; Rainbow AJ; Zhu XD
DNA Repair (Amst); 2007 Feb; 6(2):157-66. PubMed ID: 17055345
[TBL] [Abstract][Full Text] [Related]
20. DNA-PKcs-interacting protein KIP binding to TRF2 is required for the maintenance of functional telomeres.
Khadka P; Lee JH; Baek SH; Oh SY; Chung IK
Biochem J; 2014 Oct; 463(1):19-30. PubMed ID: 25012820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
